| |
|
|
|
Ocular Therapeutix Inc.  
|
|
3.94 -0.22 (-0.05%) |
03-22 16:00 |
|
Open: |
4.16 |
Pre close: |
4.16 |
Target:
|
5.20
|
|
High: |
4.215 |
Low: |
3.92 |
Resistance:
|
4.45
5.00
|
|
Volume: |
531,770 |
Market Cap: |
169M |
Support:
|
3.57
2.97
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.08
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
4.35 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
4.55 |
Stochastic Oscillator |
%K(14,3):
|
19.86 |
|
MA(250): |
5.73 |
%D(3): |
22.21  |
|
Average Volume(K) |
3-Month: |
52390
|
52-Week |
High:
|
8.28 |
|
10-Days: |
56849 |
Low: |
3.46 |
|
RSI |
RSI(14):
|
41.86 |
Change(%): |
-41.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.570 |
Return on Equity (ttm) |
-193.4 |
Shares Out. (M) |
42.84 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-93.4 |
Shares Float (M) |
41.58 |
|
EPS Est. Next Year |
-2.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.40 |
|
EPS Est. Next Quarter |
-0.530 |
Qtrly Rev. Growth |
3.5 |
% Held by Institutions |
76.20 |
|
Forward EPS |
-1.381 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.880 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.81 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-49.23 |
P/S |
3375792128.00 |
|
Operating Margin |
-2970.75 |
Levered Free Cash Flow
(M) |
-29.21 |
P/CF |
-3.43 |
|
|
|
|
|
|
